Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Cash from Operations (2016 - 2025)

Firefly Neuroscience has reported Cash from Operations over the past 15 years, most recently at 1805000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 1805000.0 for Q4 2025, down 48.19% from a year ago — trailing twelve months through Dec 2025 was 8194000.0 (down 33.13% YoY), and the annual figure for FY2025 was 8194000.0, down 33.13%.
  • Cash from Operations for Q4 2025 was 1805000.0 at Firefly Neuroscience, down from 1488000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for AIFF hit a ceiling of 491536.0 in Q3 2023 and a floor of 2584442.0 in Q4 2022.
  • Median Cash from Operations over the past 5 years was 1268500.0 (2024), compared with a mean of 1247034.5.
  • Biggest five-year swings in Cash from Operations: tumbled 1295.69% in 2022 and later skyrocketed 166.09% in 2023.
  • Firefly Neuroscience's Cash from Operations stood at 309205.0 in 2021, then tumbled by 735.83% to 2584442.0 in 2022, then skyrocketed by 80.27% to 510000.0 in 2023, then plummeted by 138.82% to 1218000.0 in 2024, then crashed by 48.19% to 1805000.0 in 2025.
  • The last three reported values for Cash from Operations were 1805000.0 (Q4 2025), 1488000.0 (Q3 2025), and 2390000.0 (Q2 2025) per Business Quant data.